Article
Polyphyllin I Overcomes EMT-Associated Resistance to Erlotinib in Lung Cancer Cells via IL-6/STAT3 Pathway Inhibition.
Biological & pharmaceutical bulletin - 1 Aug 2017
Lou Wei, Chen Yan, Zhu Ke-Ying, Deng Huizi, Wu Tianhao, Wang Jun
Abstract excerpt
Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) is the most important limiting factor for treatment efficiency in EGFR-mutant non-small cell lung cancer (NSCLC). Much work has linked the epithelial-mesenchymal transition (EMT) to the emergence of drug resistance, consequently, ongoing research has been focused on exploring the therapeutic options to reverse EMT for...
Topics
- Adenocarcinoma
- Adenocarcinoma of Lung
- Animals
- Antineoplastic Agents
- Antineoplastic Combined Chemotherapy Protocols
- Carcinoma, Non-Small-Cell Lung
- Cell Line, Tumor
- Diosgenin
- Drug Resistance, Neoplasm
- Drug Synergism
